EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial

Maria Kjølhede iD, Grethe Andersen iD, Jan Brink Valentin iD, Marlene Christina Nielsen iD, Morten Nørgaard Andersen iD, Mohammad Badruzzaman Khan iD, Jesper Nørgaard Bech iD, David C Hess iD, Rolf Ankerlund Blauenfeldt iD

Journal of the American Heart Association · 2023

DOI: 10.1161/jaha.123.031466 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Maria Kjølhede und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Aarhus University Hospital Aarhus Denmark. Hauptthemen laut MEDLINE: Biomarkers, Ischemic Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersIschemic StrokeAgedFemaleHumansMaleMiddle AgedIschemic PreconditioningPilot ProjectsTreatment Outcome

Stichwörter der Autor:innen

acute ischemic strokeremote ischemic conditioningrheo‐erythrocrine dysfunction

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology Aarhus University Hospital Aarhus Denmark.
  • Department of Clinical Medicine Aarhus University Aarhus Denmark.
  • Danish Center for Clinical Health Services Research, Department of Clinical Medicine Aalborg University Aalborg Denmark.
  • Department of Clinical Biochemistry Aarhus University Hospital Aarhus Denmark.
  • Department of Hematology Aarhus University Hospital Aarhus Denmark.
  • Department of Biomedicine Aarhus University Aarhus Denmark.

ORCID-Profile: Maria Kjølhede, Grethe Andersen, Jan Brink Valentin, Marlene Christina Nielsen, Morten Nørgaard Andersen, Mohammad Badruzzaman Khan, Jesper Nørgaard Bech, David C Hess, Rolf Ankerlund Blauenfeldt

Zitieren

APA

Kjølhede, M., Andersen, G., Valentin, J. B., Nielsen, M. C., Andersen, M. N., Khan, M. B., Bech, J. N., Hess, D. C., & Blauenfeldt, R. A. (2023). Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.031466

Vancouver

Kjølhede M, Andersen G, Valentin JB, Nielsen MC, Andersen MN, Khan MB, et al. Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial. Journal of the American Heart Association. 2023. doi:10.1161/jaha.123.031466

BibTeX
@article{Kjlhede2023,
  author = {Kjølhede, Maria and Andersen, Grethe and Valentin, Jan Brink and Nielsen, Marlene Christina and Andersen, Morten Nørgaard and Khan, Mohammad Badruzzaman and Bech, Jesper Nørgaard and Hess, David C and Blauenfeldt, Rolf Ankerlund},
  title = {Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial},
  journal = {Journal of the American Heart Association},
  year = {2023},
  doi = {10.1161/jaha.123.031466}
}
Kostenlos starten →